Man Group plc lifted its position in shares of STERIS plc (NYSE:STE - Free Report) by 288.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 5,867 shares of the medical equipment provider's stock after acquiring an additional 4,357 shares during the period. Man Group plc's holdings in STERIS were worth $1,206,000 as of its most recent filing with the SEC.
Other institutional investors have also modified their holdings of the company. Merit Financial Group LLC acquired a new stake in STERIS in the 4th quarter valued at approximately $260,000. SG Americas Securities LLC grew its stake in shares of STERIS by 655.9% in the fourth quarter. SG Americas Securities LLC now owns 10,016 shares of the medical equipment provider's stock worth $2,059,000 after purchasing an additional 8,691 shares in the last quarter. Mutual Advisors LLC increased its holdings in shares of STERIS by 15.3% during the fourth quarter. Mutual Advisors LLC now owns 2,029 shares of the medical equipment provider's stock valued at $426,000 after purchasing an additional 269 shares during the period. Exchange Traded Concepts LLC lifted its holdings in STERIS by 27.5% in the fourth quarter. Exchange Traded Concepts LLC now owns 789 shares of the medical equipment provider's stock worth $162,000 after purchasing an additional 170 shares during the period. Finally, apricus wealth LLC bought a new position in STERIS in the 4th quarter valued at about $205,000. Institutional investors own 94.69% of the company's stock.
Analyst Upgrades and Downgrades
STE has been the subject of a number of research analyst reports. Wall Street Zen raised shares of STERIS from a "buy" rating to a "strong-buy" rating in a research note on Thursday, May 22nd. Needham & Company LLC restated a "hold" rating on shares of STERIS in a research report on Monday, April 7th. Citigroup restated an "outperform" rating on shares of STERIS in a research report on Friday, May 16th. Piper Sandler upped their target price on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Finally, Stephens restated an "overweight" rating and issued a $250.00 target price on shares of STERIS in a research report on Thursday, May 15th. Two investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, STERIS has a consensus rating of "Moderate Buy" and an average target price of $264.00.
Read Our Latest Stock Report on STERIS
STERIS Stock Down 0.1%
STE traded down $0.33 during trading on Wednesday, reaching $245.87. 278,517 shares of the stock traded hands, compared to its average volume of 594,479. The stock has a market cap of $24.16 billion, a price-to-earnings ratio of 52.24 and a beta of 0.96. STERIS plc has a fifty-two week low of $200.98 and a fifty-two week high of $252.79. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The stock's 50-day simple moving average is $227.02 and its two-hundred day simple moving average is $220.44.
STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings data on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.59 by $0.15. STERIS had a return on equity of 13.91% and a net margin of 8.66%. The firm had revenue of $1.48 billion during the quarter, compared to analysts' expectations of $1.47 billion. During the same quarter last year, the firm earned $2.58 earnings per share. The business's revenue for the quarter was up 5.7% on a year-over-year basis. As a group, equities research analysts expect that STERIS plc will post 9.08 EPS for the current year.
STERIS Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, June 26th. Shareholders of record on Tuesday, June 10th will be given a $0.57 dividend. The ex-dividend date of this dividend is Tuesday, June 10th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 0.93%. STERIS's dividend payout ratio is currently 36.77%.
STERIS Profile
(
Free Report)
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Further Reading

Before you consider STERIS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.
While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.